Clinical trials
Terminated Osteoarthritis, Knee trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
88 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 11 |
| 2020 | 8 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 8 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 88 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Restor3D | 6 |
| Hospital for Special Surgery, New York | 5 |
| Biosplice Therapeutics, Inc. | 3 |
| Duke University | 3 |
| Wake Forest University Health Sciences | 3 |
| Amp Orthopedics, Inc. | 2 |
| Ampio Pharmaceuticals. Inc. | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| Minneapolis Veterans Affairs Medical Center | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoarthritis, Knee | 88 |
| Osteoarthritis | 39 |
| Osteoarthritis, Hip | 9 |
| Pain | 9 |
| Arthritis | 5 |
| Arthralgia | 4 |
| Chronic Pain | 3 |
| Joint Diseases | 3 |
| Musculoskeletal Diseases | 2 |
| Postoperative Pain | 2 |
Trials
Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.